Lipocine (NASDAQ:LPCN) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 121.43 percent decrease over earnings of $0.14 per share from the same period last year.
Related Posts
Argus Research Downgrades Atmos Energy to Hold
Argus Research analyst Gary Hovis downgrades Atmos Energy (NYSE:ATO) from Buy to Hold.
Las Vegas Sands: Q4 Earnings Insights
Las Vegas Sands (NYSE:LVS) reported its Q4 earnings results on Wednesday, January 26, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Turquoise Hill Resources Reports Amendment To Funding Deal With Rio Tinto
Turquoise Hill Resources Ltd. (TSX:TRQ) (NYSE:TRQ) ("Turquoise Hill" or the "Company") today announced that the Company and Rio Tinto International Holdings Limited (“Rio Tinto”) have